
    
      This will be a three-arm cross-sectional control-cohort outpatient evaluation. Subjects with
      sAKI and a random selection of non-sAKI subjects who agree to participate in another study of
      quality of life survey will be asked to participate in the outpatient study. Subjects will be
      asked to come in to the Clinical Research Center for 24-hour monitoring and participate in
      the outpatient study where urinary and serum studies to measure glomerular filtration rate,
      renal plasma flow followed by blood pressure monitoring, peripheral arterial and applanation
      tonometry.
    
  